- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Hematology/Oncology Clinic Welcomes Dr Sanjay Juneja
The physicians of Hematology/Oncology Clinic (HOC)—Michael Castine III, MD, Pavani Ellipeddi, MD, Lauren Juneja, MD, Christopher McCanless, MD, and Gerald Miletello, MD—are pleased to announce that medical oncologist Sanjay K. Juneja, MD, has joined the leading community oncology/hematology practice in Baton Rouge, Louisiana.
The physicians of Hematology/Oncology Clinic (HOC)—Michael Castine III, MD, Pavani Ellipeddi, MD, Lauren Juneja, MD, Christopher McCanless, MD, and Gerald Miletello, MD—are pleased to announce that medical oncologist Sanjay K. Juneja, MD, has joined the leading community oncology/hematology practice in Baton Rouge, Louisiana. A division of American Oncology Partners, LLC, HOC has office locations in Baton Rouge, at 8595 Picardy Avenue, Suite 400, and a new office in Zachary, at 1673 East Mount Pleasant Drive, Suite F-102. Juneja is practicing at both locations.
Juneja received his medical degree from Louisiana State University, where he served as student body president his fourth year. He went on to complete his internal medicine residency at Louisiana State University Health Sciences Center and was awarded resident of the year every year of his training. He was also elected president of the executive council comprised of 500-plus residents and fellow physicians. Juneja completed a fellowship in hematology/oncology at the Feist-Weiller Cancer Center in Shreveport, Louisiana, and served as chief fellow his final year. Throughout his years of medical training he was consistently recognized by his peers and faculty for his leadership, generosity, and philanthropic spirit.
For more information, see the full press release here.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
What We’re Reading: New HPV Screenings; Lung Cancer Pills; Migraine Relief Device
November 9th 2023A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines.
Read More
